19 May 2013
Keywords: ogs, pfizer, extend, proteomics, deal, uk, oxford
Article | 07 January 2002
The UK's Oxford GlycoSciences has announced that Pfizer has extended thefirms' proteomics research agreement, which was renewed in December
2000, looking ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
7 January 2002
17 May 2013
© 2013 thepharmaletter.com